| Name | Title | Contact Details |
|---|
InterProjects is a Ventura, CA-based company in the Energy and Utilities sector.
C. H. Fenstermaker and Associates, Inc is a Lafayette, LA-based company in the Energy and Utilities sector.
Second Wind s mission is to advance the use of wind data to make wind energy profitable for the businesses and investors who create wind energy plants, painless for the customers who use our products, and practical for the businesses, consumers and utilities that benefit from wind energy as a low-cost and environmentally desirable source of power.
Enevate Corporation develops and licenses advanced silicon-dominant Li-ion battery technology for electric vehicles (EVs), with a vision to charging EVs as fast as refueling gas cars and accelerating their mass adoption. Enevate`s pioneering advancements in silicon-dominant anodes and cells has resulted in its HD-Energy® and XFC-Energy(TM) technology that features 5-minute extreme fast charging with high energy density, low temperature operation for cold climates, low cost and safety advantages over conventional graphite Li-ion batteries. Enevate, with a portfolio of over 250 patents issued and pending, has raised over $110M from investors including Renault-Nissan-Mitsubishi (Alliance Ventures), LG Chem, Samsung, Mission Ventures, Draper Fisher Jurvetson, Tsing Capital, Infinite Potential Technologies, Presidio Ventures – a Sumitomo Corporation company, Lenovo, CEC Capital, Bangchak, and others. The company has its global headquarters in Irvine, California.
Reterro, Inc., provides the foremost compliant and curative green remediation solution for tens of thousands of locations worldwide that are government-mandated to clean ongoing hydrocarbon waste streams and undergo soil remediation for existing hydrocarbon contaminated waste. Uniquely effective in urban, populated and space-constrained environments in which health and safety restrictions prohibit any other competing technologies, Reterro is unrivaled in mobility, cost-effectiveness and speed-to-completion, with a record of 100% certainty of efficacy.